FDA Approved: WYOST — Original Application (Sandoz Inc)

View source ↗

Summary

FDA approved WYOST (denosumab) from Sandoz Inc under an original Biologics License Application.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases From Solid Tumors
• Hypercalcemia of Malignancy
• Osteoporosis

Drugs mentioned

• WYOST (Denosumab)

Snippet

ORIG AP for WYOST (DENOSUMAB)